Traditional drug delivery methods often suffer from a lack of specificity, leading to side effects and reduced effectiveness. For example, chemotherapy drugs can affect both cancerous and healthy cells, resulting in significant collateral damage. The primary challenge is to develop a system that can deliver drugs exclusively to targeted cells.
